Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer’s disease

Background: Blood-based biomarkers may add a great benefit in detecting the earliest neuropathological changes in patients with Alzheimer’s disease (AD). We examined the utility of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) regarding clinical diagnosis and differentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Parvizi, Tandis, König, Theresa, Wurm, Raphael, Silvaieh, Sara, Altmann, Patrick, Klotz, Sigrid, Rommer, Paulus Stefan, Furtner, Julia, Regelsberger, Günther, Lehrner, Johann, Traub-Weidinger, Tatjana, Gelpi, Ellen, Stögmann, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441692/
https://www.ncbi.nlm.nih.gov/pubmed/36072480
http://dx.doi.org/10.3389/fnagi.2022.887498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441692/
https://www.ncbi.nlm.nih.gov/pubmed/36072480
http://dx.doi.org/10.3389/fnagi.2022.887498

Ejemplares similares